Servatius, Helge
Kueffer, Thomas
Erdoes, Gabor
Seiler, Jens
Tanner, Hildegard
Noti, Fabian
Haeberlin, Andreas
Madaffari, Antonio
Branca, Mattia
Dütschler, Sophie
Theiler, Lorenz
Reichlin, Tobias
Roten, Laurent
Article History
Received: 13 February 2024
Accepted: 18 July 2024
First Online: 31 July 2024
Declarations
:
: Ethical approval for this study (N° 2018-02128) was provided by the Ethical Committee of the Kanton of Bern (Kantonale Ethikkommission, Murtenstrasse 31, Hörsaaltrakt Pathologie, Eingang 43A, Büro H372, 3010 Bern; Chairperson Prof Robert Greif) on 12 February 2019. All patients provided written informed consent to participate.
: Not applicable.
: Laurent Roten has received speaker/consulting honoraria from Abbott/SJM and from Medtronic and has received a research grant for an investigator-initiated study to the institution from Medtronic. Tobias Reichlin: Research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, and the sitem insel support funds, all for work outside the submitted study. Speaker/consulting honoraria or travel support from Abbott/SJM, Astra Zeneca, Brahms, Bayer, Biosense-Webster, Biotronik, Boston-Scientific, Daiichi Sankyo, Farapulse, Medtronic, Pfizer-BMS and Roche, all for work outside the submitted study. Support for his institution’s fellowship program from Abbott/SJM, Biosense-Webster, Biotronik, Boston-Scientific and Medtronic for work outside the submitted study. Andreas Haeberlin has received travel fees/educational grants from Medtronic, Biotronik, Abbott, and Philips/Spectranetics without impact on his personal remuneration. He serves as a proctor for Medtronic. He has received research grants from the Swiss National Science Foundation, the Swiss Innovation agency Innosuisse, the Swiss Heart Foundation, the University of Bern, the University Hospital Bern, the Velux Foundation, the Hasler Foundation, the Swiss Heart Rhythm Foundation, and the Novartis Research Foundation. He is Co-founder and CEO of Act-Inno AG. Jens Seiler: The spouse of Dr Seiler is an employee of Boston Scientific and stock owner of Boston Scientific and Abbott. Mattia Branca is affiliated with CTU Bern, University of Bern, which has a staff policy of not accepting honoraria or consultancy fees. However, CTU Bern is involved in design, conduct, or analysis of clinical studies funded by not-for-profit and for-profit organizations. In particular, pharmaceutical and medical device companies provide direct funding to some of these studies. For an up-to-date list of CTU Bern’s conflicts of interest see . All other authors declare no conflict of interest.